Twin Reversed Arterial Perfusion: To Treat or Not?
Published: January 1, 2017 | DOI: https://doi.org/10.7860/JCDR/2017/24400.9140
Sunita Dubey, Meesha Verma, Poonam Goel, RPS Punia
1. Assistant Professor, Department of Obstetrics and Gynaecology, Government Medical College and Hospital, Chandigarh, India.
2. Senior Resident, Department of Obstetrics and Gynaecology, Government Medical College and Hospital, Chandigarh, India.
3. Professor, Department of Obstetrics and Gynaecology, Government Medical College and Hospital, Chandigarh, India.
4. Professor, Department of Pathology, Government Medical College and Hospital, Chandigarh, India.
Correspondence
Dr. Sunita Dubey,
1202 B, Sector 32B, Government Medical College and Hospital Campus, Chandigarh-160030, India.
E-mail: sunitas504@gmail.com
Acardiac twinning or Twin Reverse Arterial Perfusion (TRAP)-sequence is a rare complication of monochorionic twin pregnancy. Whether to start elective or therapeutic treatment in TRAP-sequence is still controversial. In the present case, acardiac twin was not diagnosed till her delivery at 39 weeks. A healthy baby weighing 2.45 kg was delivered along with another amorphous mass (acardiac twin) of about 150 g which was attached to the placenta with a short and separate cord. As outcome of normal twin vary according to the growth of acardiac twin, frequent follow-up of the normal twin is required to look for the features of heart failure. Hence, the diagnosis of acardiac twin is essential in early pregnancy.
[
FULL TEXT ] | [ PDF]